Leadership

Personal branding and communication skills now drive funding, hiring and career growth for scientists in pharma and biotech.

AI biotech platforms can't be valued like traditional pipelines. Here's the checklist, metrics, and methods institutional investors use to price them.

ARCH, Foresite, Sequoia and a16z lead the venture capital race in AI drug discovery, see the market map and the biggest bets.

AI in drug discovery is reshaping small molecule chemistry through M&A Recursion, Exscientia, Schrödinger and Insilico lead the wave.

AI biotechs are out-licensing oncology assets to big pharma at scale. Here's how the deals work, who's leading, and why it's working.

AI cancer seed funding is surging despite a tighter market. Here's where the money flows, who backs it, and what the bets signal for pharma.

How oncology startups can use computational chemistry platforms to speed up drug discovery, cut costs, and make smarter research decisions

FDA Computer Software Assurance explained, CSA vs CSV, six step framework, SaaS validation and implementation roadmap for pharma leaders.

Remote audit prep: 6-step checklist for coordination, documents, digital tools, team training, equipment and compliance verification.

As FDA enforcement tightens, your LIMS choice is no longer an IT call — it's a quality decision with boardroom consequences.